Category: Publications

13

Oct2023
Phase 2, Multicenter Open-label Basket Trial of nab-Sirolimus for Malignant Solid Tumors Harboring Pathogenic Inactivating Alterations in TSC1 and TSC2 (PRECISION 1)
October 13, 2023John Copertino

13

Oct2023
Real-world (RW) characterization and frequency of TSC1 and/or TSC2 alterations collected from tumor tissue and liquid biopsies from the Tempus genomic database in patients with advanced cancer
October 13, 2023John Copertino

12

Oct2023
Evaluation of nab-Sirolimus in Combination With PI3K Pathway Inhibitors to Overcome PI3K/mTOR A117Resistance in PI3K-Mutant Breast Cancer Cell Lines
October 12, 2023webmaster

05

Oct2023
October 5, 2023webmaster

05

Oct2023
October 5, 2023webmaster

02

Jun2023
Solid Tumors Harboring Pathogenic Inactivating Alterations in TSC1 or TSC2 Genes (PRECISION 1)
June 2, 2023John Copertino

19

Apr2023
April 19, 2023webmaster

18

Apr2023
April 18, 2023webmaster

17

Apr2023
April 17, 2023webmaster

26

Mar2023
March 26, 2023John Copertino